Welcome to our dedicated page for Sherwin-Williams SEC filings (Ticker: SHW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sherwin-Williams Company filings document operating results, governance actions, and capital-structure matters for an Ohio paint and coatings issuer with common stock listed on the New York Stock Exchange under SHW. Recent Form 8-K reports furnish quarterly and annual financial results, including net sales, earnings measures, segment performance, guidance, and Valspar acquisition-related amortization.
Proxy and annual-meeting filings cover director elections, advisory executive-compensation votes, auditor ratification, shareholder voting results, and pay-versus-performance disclosures. Other 8-K filings record material definitive agreements, amendments to credit facilities, borrowing and letter-of-credit commitments, covenants, events of default, and related direct financial obligations.
Sherwin-Williams (SHW) reported an insider equity grant: its SVP–CHRO received 6,060 employee stock options with an exercise price of $331.37 per share on October 20, 2025, under the 2025 Equity and Incentive Compensation Plan.
The options vest in three substantially equal annual installments starting October 20, 2026, and expire on October 19, 2035. This is a standard compensation award that sets the right to buy common stock at a fixed price over time as service-based vesting conditions are met.
Sherwin-Williams (SHW) disclosed a routine insider equity grant. The company’s President, Consumer Brands Group, reported the award of 4,595 employee stock options on October 20, 2025 with an exercise price of $331.37 and expiration on October 19, 2035.
The options vest in three substantially equal annual installments beginning October 20, 2026, under the 2025 Equity and Incentive Compensation Plan. Following this grant, the reporting person beneficially owns 4,595 derivative securities, held directly. This filing reflects standard compensation rather than an open‑market transaction.
Sherwin-Williams (SHW) reported an insider equity award. The company’s SVP – Corp Strategy & Devel. received an employee stock option grant for 3,340 shares at an exercise price of $331.37 on 10/20/2025, recorded as an acquisition. The options expire on 10/19/2035 and were reported as Direct ownership.
The award vests annually in three substantially equal installments commencing 10/20/2026, pursuant to the 2025 Equity and Incentive Compensation Plan. The derivative security price was reported as $0.
Sherwin-Williams (SHW) reported an insider equity award on Form 4. An officer (SVP – IR & Corp. Comm.) was granted an employee stock option to purchase 2,510 shares at an exercise price of $331.37 on October 20, 2025. The options expire on October 19, 2035 and vest annually in three substantially equal installments commencing October 20, 2026, subject to vesting conditions. Following the grant, 2,510 derivative securities were beneficially owned directly.
Sherwin-Williams (SHW) reported an insider equity grant for its SVP – Enterprise Finance & CAO. A Form 4 discloses the award of 2,300 employee stock options at an exercise price of $331.37 per share on 10/20/2025.
The options were granted under the 2025 Equity and Incentive Compensation Plan and vest annually in three substantially equal installments beginning 10/20/2026, subject to vesting conditions. The options expire on 10/19/2035. Following the transaction, the reporting person beneficially owned 2,300 derivative securities, held directly.
Thomas Williams, a company director at Sherwin-Williams (SHW), received deferred equity under the 2005 Director Deferred Fee Plan on 10/03/2025. The filing reports 1,813 deferred stock units and common shares credited to his account, calculated using a weighted average share price of $343.81 to determine unit amounts. The deferred stock units are payable only in stock, generally after the director leaves service, and include units credited via a dividend reinvestment feature. The filing also notes ownership following the transaction of 953.23 (reported as beneficially owned) under an indirect form, and that 1,147 RSUs plus 666 shares comprise the 1,813 figure.
Sherwin-Williams Co. (SHW) director Michael H. Thaman reported changes in his beneficial ownership on 10/03/2025 in a Form 4 filing. The filing shows an acquisition of deferred stock units under the 2005 Director Deferred Fee Plan and a disposition of 7,553 common stock-related holdings. The filing states 98.17 deferred stock units were credited using a weighted average share price of $343.81, and it lists 5,370.62 as the amount of securities beneficially owned following the transaction (identified as indirect ownership). The disposition entry lists 7,553 which the filing explains consists of 1,150 restricted stock units and 6,403 shares of common stock. The deferred units are payable solely in stock and generally become payable after the reporting person separates from service as a director.
Robert J. Gamgort, a director of Sherwin-Williams Co. (SHW), reported changes in his beneficial ownership on 10/03/2025. He acquired 98.17 deferred stock units under the 2005 Director Deferred Fee Plan at a weighted average price of $343.81, and disposed of 517 restricted stock units (RSUs). After the reported transactions he beneficially owns 281.71 deferred stock units held indirectly; the deferred units are payable in shares following separation from service.
Kerrii B. Anderson, a director of Sherwin-Williams (SHW), reported changes in beneficial ownership on 10/03/2025. The filing shows the director acquired deferred stock units under the 2005 Director Deferred Fee Plan equal to 29.09 units at a weighted average price of $343.81 per share; those deferred units are payable in stock, generally after separation from service. The report also shows a disposition of 5,261 common stock-related instruments, comprised of 1,150 restricted stock units (RSUs) and 4,111 shares of common stock. Following the transaction, the reporting person beneficially owned 979.69 deferred stock units indirectly.
Sherwin-Williams completed a strategic acquisition and secured short-term financing to fund it. The company and its Luxembourg unit entered a 364-day senior unsecured delayed draw term loan agreement providing a $750 million USD tranche and a e2 82 ac250 million EUR tranche, and on September 25, 2025 both tranches were drawn to fund part of a previously announced transaction. On October 1, 2025 a wholly owned Brazilian subsidiary closed the purchase of Suvinil Coatings S.A., BASFs Brazilian architectural paints business, for $1.15 billion, subject to customary working capital and post-closing adjustments.